Crossmark

In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates

Crossref DOI link: https://doi.org/10.1186/s40001-024-01885-6

Published Online: 2024-06-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Müderris, Tuba

Dursun Manyaslı, Gülden

Sezak, Nurbanu

Kaya, Selçuk

Demirdal, Tuna

Gül Yurtsever, Süreyya
Funding

Funding for this research was provided by:

İzmir Katip Çelebi University Scientific Research Projects (2018.GAP.TIPF.0006)
License Information

Text and Data Mining valid from 2024-06-16

Version of Record valid from 2024-06-16
More Information

Article History

Received: 27 February 2024

Accepted: 14 May 2024

First Online: 16 June 2024

Declarations

:

: The ethics committee approval of this study was approved by the İzmir Katip Çelebi University clinical research ethics committee (2018.KAE.0170).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below